Insider Transactions in Q2 2024 at Repligen Corp (RGEN)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2024
|
Martin D Madaus |
BUY
Open market or private purchase
|
Direct |
1,615
+16.06%
|
$201,875
$125.0 P/Share
|
|
Jun 14
2024
|
Anthony Hunt |
BUY
Open market or private purchase
|
Direct |
2,000
+1.2%
|
$248,000
$124.08 P/Share
|
|
Jun 14
2024
|
Nicolas Barthelemy |
BUY
Open market or private purchase
|
Direct |
1,200
+20.45%
|
$150,000
$125.45 P/Share
|
|
Jun 14
2024
|
Karen A Dawes |
BUY
Exercise of conversion of derivative security
|
Direct |
2,953
+3.24%
|
$197,851
$67.71 P/Share
|
|
May 21
2024
|
Anthony Hunt |
SELL
Open market or private sale
|
Direct |
20,072
-1.91%
|
$3,372,096
$168.68 P/Share
|
|
May 16
2024
|
Martin D Madaus |
BUY
Grant, award, or other acquisition
|
Direct |
701
+18.95%
|
-
|
|
May 16
2024
|
Margaret Pax |
BUY
Grant, award, or other acquisition
|
Direct |
701
+46.92%
|
-
|
|
May 16
2024
|
Rohin Mhatre |
BUY
Grant, award, or other acquisition
|
Direct |
701
+18.71%
|
-
|
|
May 16
2024
|
Konstantin Konstantinov |
BUY
Grant, award, or other acquisition
|
Direct |
701
+26.74%
|
-
|
|
May 16
2024
|
Karen A Dawes |
BUY
Grant, award, or other acquisition
|
Direct |
803
+0.9%
|
-
|
|
May 16
2024
|
Nicolas Barthelemy |
BUY
Grant, award, or other acquisition
|
Direct |
701
+16.81%
|
-
|
|
May 16
2024
|
Manner Carrie Eglinton |
BUY
Grant, award, or other acquisition
|
Direct |
701
+16.71%
|
-
|
|
May 16
2024
|
Glenn P Muir |
BUY
Grant, award, or other acquisition
|
Direct |
701
+7.8%
|
-
|
|
May 14
2024
|
Ralf Kuriyel Senior VP, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
534
-2.2%
|
$87,042
$163.34 P/Share
|
|
May 14
2024
|
Christine Gebski |
SELL
Payment of exercise price or tax liability
|
Direct |
334
-1.2%
|
$54,442
$163.34 P/Share
|
|
Apr 02
2024
|
James Bylund Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
444
-2.11%
|
$80,808
$182.95 P/Share
|